What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Surgery
Richard J.H. Smith mainly focuses on Genetics, Hearing loss, Genetic testing, Gene and Surgery.
His is doing research in Mutation, Locus, Missense mutation, Allele and Usher syndrome, both of which are found in Genetics.
His Sensorineural hearing loss and Congenital hearing loss study in the realm of Hearing loss interacts with subjects such as GJB6.
His Genetic testing research is multidisciplinary, incorporating elements of Bioinformatics, Medical genetics, Genomics, Exome and Massive parallel sequencing.
Richard J.H. Smith has researched Gene in several fields, including Consanguinity and Molecular biology.
His Audiology research is multidisciplinary, incorporating perspectives in Genetic counseling and Pediatrics.
His most cited work include:
- A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration (1738 citations)
- Body mass in comparative primatology (1035 citations)
- Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project (823 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Genetics, Hearing loss, Surgery, Gene and Audiology.
His study in Locus, Genetic linkage, Allele, Missense mutation and Mutation are all subfields of Genetics.
His Hearing loss study incorporates themes from Phenotype, Genetic counseling and Genetic testing.
His work in Genetic testing is not limited to one particular discipline; it also encompasses Massive parallel sequencing.
He most often published in these fields:
- Genetics (23.07%)
- Hearing loss (19.48%)
- Surgery (8.77%)
What were the highlights of his more recent work (between 2015-2021)?
- Hearing loss (19.48%)
- Genetics (23.07%)
- Genetic testing (7.80%)
In recent papers he was focusing on the following fields of study:
His main research concerns Hearing loss, Genetics, Genetic testing, MEDLINE and Glomerulopathy.
His Hearing loss study combines topics in areas such as Exome sequencing and Missense mutation.
His study in Gene, RNA splicing and Exon is carried out as part of his Genetics studies.
He interconnects Massive parallel sequencing, Bioinformatics and MYO15A in the investigation of issues within Genetic testing.
His Glomerulopathy research integrates issues from Alternative complement pathway, Atypical hemolytic uremic syndrome, Disease and Immunology.
Richard J.H. Smith is interested in Complement system, which is a branch of Immunology.
Between 2015 and 2021, his most popular works were:
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (254 citations)
- Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss (175 citations)
- Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss (175 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Surgery
The scientist’s investigation covers issues in Hearing loss, Genetic testing, Genetics, Audiology and Complement system.
His Hearing loss study combines topics from a wide range of disciplines, such as Hair cell, Inner ear, Cochlea and Locus.
The study incorporates disciplines such as Bioinformatics, Hearing screening, Intensive care medicine, Massive parallel sequencing and MYO15A in addition to Genetic testing.
His works in Gene, Missense mutation, CFHR5, Human genetics and Minor allele frequency are all subjects of inquiry into Genetics.
His study on Sensorineural hearing loss and Congenital hearing loss is often connected to Habilitation as part of broader study in Audiology.
His Immunology study also includes fields such as
- Glomerulonephritis which is related to area like Renal pathology,
- Disease and related Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
